成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

  2. Anti-infection Cell Cycle/DNA Damage
  3. Bacterial Antibiotic DNA/RNA Synthesis
  4. Erythromycin thiocyanate

Erythromycin thiocyanate  (Synonyms: 紅霉素硫氰酸鹽)

目錄號: HY-B0220D 純度: 96.42%
COA 產(chǎn)品使用指南 技術(shù)支持

Erythromycin thiocyanate 是由放線菌產(chǎn)生的大環(huán)內(nèi)酯類抗生素 (antibiotic)，具有廣泛的抗菌活性。Erythromycin thiocyanate 通過結(jié)合細菌的 50S 核糖體亞基而起作用，并通過阻斷轉(zhuǎn)肽和/或易位反應來抑制 RNA 依賴性蛋白 (RNA-dependent protein synthesis) 的合成，而不會影響核酸的合成。Erythromycin thiocyanate 在不同領域的研究中顯示出抗腫瘤特性和保護神經(jīng)的作用。

MCE 的所有產(chǎn)品僅用作科學研究或藥證申報，我們不為任何個人用途提供產(chǎn)品和服務

Erythromycin thiocyanate Chemical Structure

Erythromycin thiocyanate Chemical Structure

CAS No. : 7704-67-8

1.  客戶無需承擔相應的運輸費用。

2.  同一機構(gòu)（單位）同一產(chǎn)品試用裝僅限申領一次，同一機構(gòu)（單位）一年內(nèi)

     可免費申領三個不同產(chǎn)品的試用裝。

3.  試用裝只面向終端客戶。

規(guī)格 價格 是否有貨 數(shù)量
Free Sample (0.1 - 0.2 mg)   Apply now  
10 mM * 1 mL in DMSO ￥275
In-stock
1 g ￥250
In-stock
5 g ￥550
In-stock
10 g   詢價  
50 g   詢價  

* Please select Quantity before adding items.

  • 生物活性

  • 純度 & 產(chǎn)品資料

  • 參考文獻

生物活性

Erythromycin thiocyanate is a macrolide antibiotic produced by actinomycete?Streptomyces erythreus?with a broad spectrum of antimicrobial activity. Erythromycin thiocyanate binds to bacterial 50S ribosomal subunits and inhibits?RNA-dependent protein synthesis?by blockage of transpeptidation and/or translocation reactions, without affecting synthesis of nucleic acid[1][2]. Erythromycin thiocyanate also exhibits antitumor and neuroprotective effect in different fields of research[3][4].

IC50 & Target

Macrolide

 

細胞效力
(Cellular Effect)
Cell Line Type Value Description References
HEK293 IC50
> 500 μM
Compound: erythromycin
Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay
Inhibition of human MATE1-mediated ASP+ uptake expressed in HEK293 cells after 1.5 mins by fluorescence assay
[PMID: 23241029]
HeLa IC50
> 400 μg/mL
Compound: Erythromycin
Antiproliferative effect against HeLa cells after 48 hrs
Antiproliferative effect against HeLa cells after 48 hrs
[PMID: 17088489]
HeLa IC50
170 μg/mL
Compound: Erythromycin
Inhibition of metabolic activity in HeLa cells assessed as MTT reduction after 48 hrs
Inhibition of metabolic activity in HeLa cells assessed as MTT reduction after 48 hrs
[PMID: 17088489]
HFF CC50
475 μM
Compound: 1
Cytotoxicity against HFF after 48 hrs by MTS assay
Cytotoxicity against HFF after 48 hrs by MTS assay
[PMID: 21428405]
LLC-PK1 IC50
> 35 μM
Compound: Erythromycin
Inhibition of P-glycoprotein, mouse L-mdr1b expressed in LLC-PK1 epithelial cells using calcein-AM polarisation assay
Inhibition of P-glycoprotein, mouse L-mdr1b expressed in LLC-PK1 epithelial cells using calcein-AM polarisation assay
[PMID: 12699389]
LLC-PK1 IC50
> 50 μM
Compound: Erythromycin
Inhibition of P-glycoprotein, human L-MDR1 expressed in LLC-PK1 epithelial cells using calcein-AM polarisation assay
Inhibition of P-glycoprotein, human L-MDR1 expressed in LLC-PK1 epithelial cells using calcein-AM polarisation assay
[PMID: 12699389]
LLC-PK1 IC50
> 50 μM
Compound: Erythromycin
Inhibition of P-glycoprotein, mouse L-mdr1a expressed in LLC-PK1 epithelial cells using calcein-AM polarisation assay
Inhibition of P-glycoprotein, mouse L-mdr1a expressed in LLC-PK1 epithelial cells using calcein-AM polarisation assay
[PMID: 12699389]
MG-63 IC50
300 μg/mL
Compound: Erythromycin
Antiproliferative effect against MG63 cells assessed as BrdU incorporation into DNA after 48 hrs after 48 hrs
Antiproliferative effect against MG63 cells assessed as BrdU incorporation into DNA after 48 hrs after 48 hrs
[PMID: 17088489]
MG-63 IC50
310 μg/mL
Compound: Erythromycin
Inhibition of metabolic activity in MG63 cells assessed as MTT reduction after 48 hrs
Inhibition of metabolic activity in MG63 cells assessed as MTT reduction after 48 hrs
[PMID: 17088489]
Osteoblast IC50
> 400 μg/mL
Compound: Erythromycin
Inhibition of metabolic activity in primary human osteoblasts assessed as MTT reduction after 48 hrs
Inhibition of metabolic activity in primary human osteoblasts assessed as MTT reduction after 48 hrs
[PMID: 17088489]
Osteoblast IC50
180 μg/mL
Compound: Erythromycin
Antiproliferative effect against primary human osteoblasts assessed as BrdU incorporation into DNA after 48 hrs
Antiproliferative effect against primary human osteoblasts assessed as BrdU incorporation into DNA after 48 hrs
[PMID: 17088489]
體外研究
(In Vitro)

Erythromycin thiocyanate inhibits growth of P. falciparum with IC50 and IC90 values of 58.2 μM and 104.0 μM, respectively[1].
Erythromycin thiocyanate (10 μM, 100 μM; 24 h, 72 h) shows antioxidant and anti-inflammatory effects and suppresses the accumulation of 4-HNE (p<0.01) and 8-OHdG (p<0.01), reduces Iba-1 (p<0.01) and TNF-α (p<0.01) expression significantly[4].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay[4]

Cell Line: Embryos primary cortical neuron (from the cerebral cortices of 17-day-old Sprague-Dawley rat)
Concentration: 10, 100 μM
Incubation Time: 24, 72 hours
Result: Improved the viability of cultured neuronal cells in vitro after 3 hours oxygen-glucose deprivation (OGD).
體內(nèi)研究
(In Vivo)

Erythromycin thiocyanate (gastric intubation; 0.1-50 mg/kg; 30-120 days) decreases tumor growth and prolong the survival time of mice from dose of 5 mg/kg in mice[3].
Erythromycin thiocyanate (gastric intubation; 5 mg/kg) protects mice alive even at 120 days after inoculation, but shortens mean survival time in tumor-bearing mice by 4-5 days with dose of 50 mg/kg[3].
Erythromycin thiocyanate (i.h.; single injection; 50 mg/kg) has a protective effect on the rat model with cerebral ischemia reperfusion-injury[4].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Female ddY mice (6-week-old) with EAC cells or CDF mice (6-week-old) with P388 cells[3]
Dosage: 0.1 mg/kg; 0.5 mg/kg; 10 mg/kg; 30 mg/kg; 50 mg/kg
Administration: Gastric intubation; 30-120 days
Result: Decreased tumor growth and prolonged the mean survival time of mice from the dose of 5 mg/kg, however, the 50 mg/kg dosage shortened the MST in tumorbearing mice.
Animal Model: Male Sprague-Dawley rats (8-week-old, 250-300 g)[4]
Dosage: 50 mg/kg
Administration: Subcutaneous single injection
Result: Reduced infarct volume and edema volume, improved neurological deficit.
Clinical Trial
分子量

793.02

Formula

C38H68N2O13S
CAS 號
性狀

固體

顏色

White to off-white

中文名稱

紅霉素硫氰酸鹽
結(jié)構(gòu)分類
初始來源

Streptomyces erythreHs
運輸條件

Room temperature in continental US; may vary elsewhere.
儲存方式

-20°C, sealed storage, away from moisture

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

溶解性數(shù)據(jù)
細胞實驗： 

DMSO 中的溶解度 : 100 mg/mL (126.10 mM; 超聲助溶; 吸濕的 DMSO 對產(chǎn)品的溶解度有顯著影響，請使用新開封的 DMSO)

配制儲備液
濃度 溶劑體積 質(zhì)量 1 mg 5 mg 10 mg
1 mM 1.2610 mL 6.3050 mL 12.6100 mL
5 mM 0.2522 mL 1.2610 mL 2.5220 mL
查看完整儲備液配制表

* 請根據(jù)產(chǎn)品在不同溶劑中的溶解度選擇合適的溶劑配制儲備液；一旦配成溶液，請分裝保存，避免反復凍融造成的產(chǎn)品失效。
儲備液的保存方式和期限：-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)。-80°C儲存時，請在6個月內(nèi)使用，-20°C儲存時，請在1個月內(nèi)使用。

  • 摩爾計算器

  • 稀釋計算器

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

質(zhì)量
=
濃度
×
體積
×
分子量 *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

濃度 (start)

C1

×
體積 (start)

V1

=
濃度 (final)

C2

×
體積 (final)

V2

掃碼獲得
動物溶解方案

動物溶解方案計算器
請輸入動物實驗的基本信息：

給藥劑量

mg/kg

動物的平均體重

g

每只動物的給藥體積

μL

動物數(shù)量

只
由于實驗過程有損耗，建議您多配一只動物的量
純度 & 產(chǎn)品資料
參考文獻

完整儲備液配制表

* 請根據(jù)產(chǎn)品在不同溶劑中的溶解度選擇合適的溶劑配制儲備液；一旦配成溶液，請分裝保存，避免反復凍融造成的產(chǎn)品失效。
儲備液的保存方式和期限：-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)。-80°C儲存時，請在6個月內(nèi)使用，-20°C儲存時，請在1個月內(nèi)使用。

可選溶劑 濃度 溶劑體積 質(zhì)量 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 1.2610 mL 6.3050 mL 12.6100 mL 31.5251 mL
5 mM 0.2522 mL 1.2610 mL 2.5220 mL 6.3050 mL
10 mM 0.1261 mL 0.6305 mL 1.2610 mL 3.1525 mL
15 mM 0.0841 mL 0.4203 mL 0.8407 mL 2.1017 mL
20 mM 0.0631 mL 0.3153 mL 0.6305 mL 1.5763 mL
25 mM 0.0504 mL 0.2522 mL 0.5044 mL 1.2610 mL
30 mM 0.0420 mL 0.2102 mL 0.4203 mL 1.0508 mL
40 mM 0.0315 mL 0.1576 mL 0.3153 mL 0.7881 mL
50 mM 0.0252 mL 0.1261 mL 0.2522 mL 0.6305 mL
60 mM 0.0210 mL 0.1051 mL 0.2102 mL 0.5254 mL
80 mM 0.0158 mL 0.0788 mL 0.1576 mL 0.3941 mL
100 mM 0.0126 mL 0.0631 mL 0.1261 mL 0.3153 mL

您最近查看的產(chǎn)品:

Your information is safe with us. * Required Fields.

   產(chǎn)品名稱：

  

* 需求量：

* 客戶姓名：

 

* Email：

* 電話：

 

* 公司或機構(gòu)名稱：

   留言給我們：

Bulk Inquiry

Inquiry Information

產(chǎn)品名稱：
Erythromycin thiocyanate
目錄號：
HY-B0220D
需求量：
我們的 Cookie 政策

我們使用 Cookies 和類似技術(shù)以提高網(wǎng)站的性能和提升您的瀏覽體驗，部分功能也使用 Cookies 幫助我們更好地理解您的需求，為您提供相關(guān)的服務。 如果您有任何關(guān)于我們?nèi)绾翁幚砟鷤€人信息的疑問，請閱讀我們的《隱私聲明》。